Serina Therapeutics Welcomes Gregory Curhan as New CFO

Serina Therapeutics (SER) has shared an update.

Gregory S. Curhan has been appointed as the new Chief Financial Officer of Serina Therapeutics, Inc., bringing a wealth of experience from his current partner role at FLG Partners and as CFO for Curevo Vaccines. With his strong background in financial leadership roles and a B.A. in Economics from Dartmouth College, Curhan will earn $650 per hour and has been granted an option to purchase 250,000 company shares. This strategic move follows the departure of interim CFO Andrea Park, marking a new chapter in Serina Therapeutics’ financial management.

For an in-depth examination of SER stock, go to TipRanks’ Stock Analysis page.